Please login to the form below

Not currently logged in
Email:
Password:

EFPIA looks to ABPI for comms director

Andrew Powrie-Smith will join EU pharma trade body in New Year
Andrew Powrie-Smith

Andrew Powrie-Smith has left his role at the Association of the British Pharmaceutical Industry (ABPI) to join its European equivalent as communications director.

Powrie-Smith replaces Liam English in the role at the European Federation of Pharmaceutical Industries and Associations (EFPIA), who left the role just five months after joining in May 2014 to move back to the UK. He is now working at the ABPI on a communication project for Stephen Whitehead, CEO of the ABPI.

Powrie-Smith is currently director of the ABPI's operations in Scotland and also heads the trade body's Trust and Reputation network.

He has great experience in the not-for-profit sector, including a spell as director of the British Lung Foundation, where he campaigned to improve clinical standards in respiratory disorders, as well as positions at the British Red Cross, Amnesty International and Scope. 

Commenting on his new role, Powrie-Smith said: "I am delighted to be joining the team at EFPIA. Our industry faces some unprecedented challenges across a range of issues, but I am passionate about the story we have to tell and the difference we make to the lives of patients and their families, right across Europe.”

3rd December 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Top Pharma News

TopPharmaNews.com is a global pharma magazine dedicated to delivering fresh news to society. The team at the TopPharmaNews.com cater non-biased,...

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics